Ryanodine receptor (RYR) mutations confer stress-triggered malignant hyperthermia (MH) susceptibility. Dietary caffeine (CAF) is the most commonly consumed psychoactive compound by humans. CAF-triggered Ca2+ release and its influences on skeletal muscle contractility are widely used as experimental tools to study RYR function/dysfunction and diagnose MH susceptibility. We hypothesize that dietary CAF achieving blood levels measured in human plasma exacerbates the penetrance of RYR1 MH susceptibility mutations triggered by gaseous anesthetic, affecting both central and peripheral adverse responses. Heterozygous R163C-RYR1 (HET) MH susceptible mice are used to investigate the influences of dietary CAF on both peripheral and central responses ...
Malignant hyperthermia (MH) is a fatal hypermetabolic state that may occur during general anesthesia...
Malignant hyperthermia (MH) and central core disease (CCD) are caused by mutations in the RYR1 gene ...
3,5-Di-t-butyl catechol (DTCAT) releases Ca(2+) from rat skeletal muscle sarcoplasmic reticulum (SR)...
grantor: University of TorontoMalignant hyperthermia (MH) and central core disease (CCD) a...
Background: The human p.G2434R variant of the RYR1 gene is most frequently associated with malignan...
SummaryMalignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that is triggere...
Enhanced sensitivity to caffeine is part of the standard tests for susceptibility to malignant hyper...
Malignant hyperthermia (MH), a rare autosomal dominant pharmacogenetic disorder of skeletal muscle c...
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that is triggered in ge...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder triggered by exposure to...
Background: Malignant hyperthermia (MH) is a rare pharmacogenetic disorder which is characterized by...
Skeletal muscle from normal human subjects produced linear contracture responses in vitro to caffein...
BACKGROUND: Malignant hyperthermia is a pharmacogenetic disorder affecting humans, dogs, pigs, and h...
Malignant hyperthermia (MH) is a potential fatal hereditary skeletal muscle disorder that occurs upo...
Background. We investigated the potential safety of remimazolam and propofol in malignant hypertherm...
Malignant hyperthermia (MH) is a fatal hypermetabolic state that may occur during general anesthesia...
Malignant hyperthermia (MH) and central core disease (CCD) are caused by mutations in the RYR1 gene ...
3,5-Di-t-butyl catechol (DTCAT) releases Ca(2+) from rat skeletal muscle sarcoplasmic reticulum (SR)...
grantor: University of TorontoMalignant hyperthermia (MH) and central core disease (CCD) a...
Background: The human p.G2434R variant of the RYR1 gene is most frequently associated with malignan...
SummaryMalignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that is triggere...
Enhanced sensitivity to caffeine is part of the standard tests for susceptibility to malignant hyper...
Malignant hyperthermia (MH), a rare autosomal dominant pharmacogenetic disorder of skeletal muscle c...
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that is triggered in ge...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder triggered by exposure to...
Background: Malignant hyperthermia (MH) is a rare pharmacogenetic disorder which is characterized by...
Skeletal muscle from normal human subjects produced linear contracture responses in vitro to caffein...
BACKGROUND: Malignant hyperthermia is a pharmacogenetic disorder affecting humans, dogs, pigs, and h...
Malignant hyperthermia (MH) is a potential fatal hereditary skeletal muscle disorder that occurs upo...
Background. We investigated the potential safety of remimazolam and propofol in malignant hypertherm...
Malignant hyperthermia (MH) is a fatal hypermetabolic state that may occur during general anesthesia...
Malignant hyperthermia (MH) and central core disease (CCD) are caused by mutations in the RYR1 gene ...
3,5-Di-t-butyl catechol (DTCAT) releases Ca(2+) from rat skeletal muscle sarcoplasmic reticulum (SR)...